Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 4
1982 3
1983 5
1984 5
1985 2
1986 1
1987 3
1988 3
1989 2
1990 3
1991 3
1992 5
1993 1
1994 2
1995 6
1996 5
1997 4
1998 4
1999 2
2000 1
2001 3
2002 2
2003 2
2006 2
2007 2
2009 1
2010 4
2011 4
2012 1
2014 4
2015 5
2016 2
2017 2
2018 3
2019 4
2020 2
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.
Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF; IMPACT Study Investigators. Kantoff PW, et al. N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294. N Engl J Med. 2010. PMID: 20818862 Free article. Clinical Trial.
Going Back.
Leichman L. Leichman L. Oncologist. 2021 Jan;26(1):86-87. doi: 10.1634/theoncologist.2020-0628. Epub 2020 Aug 17. Oncologist. 2021. PMID: 32627288 Free PMC article.
Anal carcinoma.
Leichman LP, Cummings BJ. Leichman LP, et al. Curr Probl Cancer. 1990 May-Jun;14(3):117-59. doi: 10.1016/0147-0272(90)90014-h. Curr Probl Cancer. 1990. PMID: 2202554 Review.
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL. Cooper JS, et al. Among authors: leichman ll. JAMA. 1999 May 5;281(17):1623-7. doi: 10.1001/jama.281.17.1623. JAMA. 1999. PMID: 10235156 Clinical Trial.
NO147: the Giving Tree.
Leichman L. Leichman L. J Natl Cancer Inst. 2014 Jun 12;106(7):dju123. doi: 10.1093/jnci/dju123. Print 2014 Jul. J Natl Cancer Inst. 2014. PMID: 24925351 No abstract available.
The current status of neoadjuvant therapy for esophageal cancer.
Lin D, Leichman L. Lin D, et al. Among authors: leichman l. Semin Thorac Cardiovasc Surg. 2014 Summer;26(2):102-9. doi: 10.1053/j.semtcvs.2014.07.002. Epub 2014 Jul 16. Semin Thorac Cardiovasc Surg. 2014. PMID: 25441001 Review.
Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
Safran HP, Winter K, Ilson DH, Wigle D, DiPetrillo T, Haddock MG, Hong TS, Leichman LP, Rajdev L, Resnick M, Kachnic LA, Seaward S, Mamon H, Diaz Pardo DA, Anderson CM, Shen X, Sharma AK, Katz AW, Salo J, Leonard KL, Moughan J, Crane CH. Safran HP, et al. Among authors: leichman lp. Lancet Oncol. 2022 Feb;23(2):259-269. doi: 10.1016/S1470-2045(21)00718-X. Epub 2022 Jan 14. Lancet Oncol. 2022. PMID: 35038433 Free PMC article. Clinical Trial.
104 results